CP-690,550 Thorough QTc Study

NCT01743677 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CP-690,550
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Pfizer